Skip to content

Randomized comparative clinical trial for etiopathological study of participants of Shvitra (Vitiligo) with intervention of Putikadi lepa and Avalguja Bijadi lepa along with Patoladi kwath with special reference to Vitiligo

Randomized comparative clinical trial for etiopathological study of Shvitra (Vitiligo) with Putikadi lepa and Avalguja Bijadi lepa along with Patoladi kwath w.s.r. to Vitiligo - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067381
Enrollment
100
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

National Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A. Inclusion Criteria : 1.Patients with SadhyaLakshana of Shvitra i.e. Araktaloma [Small hair over the patches are not red ] Tanu Pandu [Skin is thin and white] Naticirotthitam [Recent origin] Madhyavakashe Cocchunum [Space between two patches is elevated] 2.Diagnosed cases of uncomplicated segmental or generalized leucoderma involving either of sexes in the age group 18 to 70 year of age will be registered.

Exclusion criteria

Exclusion criteria: B. Exclusion Criteria : 1.Patient below 18 and above 70 year of age. 2.White anaesthetic spots, which are characteristics of leprosy will be excluded from the study. 3.Old refractory cases not responding after extensive use of modern medicine. 4.Vitiligo patches complicated by eczema and secondary infections. 5.Patient suffering from major illness. 6.Pregnant women and lactation mother. 7.Patient with history of trauma and burn. 8.Patient with Albinism will be excluded.

Design outcomes

Primary

MeasureTime frame
Change in Vasi Score and CBC , ESR , RBS in both groups before and after treatment. Timepoint: Changes will be observed in 0,15,45 and 60 days.

Secondary

MeasureTime frame
1.Strength of association between Nidan and Shvitra (Vitiligo). 2.Change in classical signs and symptoms of Shvitra before and after treatment. Timepoint: Changes will be observed in 0,15,45 and 60 days

Countries

India

Contacts

Public ContactProf B K Sevatkar

National Institute Of Ayurveda

drbks6@gmail.com9352311105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026